Park Avenue Securities LLC Neurocrine Biosciences Inc Transaction History
Park Avenue Securities LLC
- $8.9 Billion
- Q3 2024
A detailed history of Park Avenue Securities LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Park Avenue Securities LLC holds 5,744 shares of NBIX stock, worth $679,630. This represents 0.01% of its overall portfolio holdings.
Number of Shares
5,744
Previous 9,933
42.17%
Holding current value
$679,630
Previous $1.37 Million
51.57%
% of portfolio
0.01%
Previous 0.02%
Shares
16 transactions
Others Institutions Holding NBIX
# of Institutions
637Shares Held
95.2MCall Options Held
661KPut Options Held
227K-
Black Rock Inc. New York, NY14.2MShares$1.68 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$1.19 Billion0.03% of portfolio
-
State Street Corp Boston, MA4.61MShares$545 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.47MShares$292 Million0.6% of portfolio
-
Jpmorgan Chase & CO New York, NY2.36MShares$280 Million0.03% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $11.3B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...